ALFA FinderBSE filing, NSE: GANGAPHARM. Summary written from the filing by ALFA Finder's alert engine.
More from Ganga Pharmaceuticals Ltd
All →Ganga Pharmaceuticals Annual General Meeting
Ganga Pharmaceuticals Limited held its 37th Annual General Meeting on September 26, 2026. The filing records the meeting proceedings and conduct of business.
Other management change announcements
All →Edelweiss Financial Services Management Change
Promoter director Venkatachalam Ramaswamy resigned as Non-Executive Director and Vice Chairman effective November 11, 2026. He also sought reclassification from promoter to public category, pending approvals.
Abans Financial Services Management Change
Abans Financial Services' Chief Executive Officer Chintan Mehta resigned with immediate effect. Mayank Mundhra was appointed Whole-Time Director from November 11, 2026, subject to shareholder approval.
Ortin Global Management Change
Ortin Global's auditor M/s. Mathesh & Ramana resigned effective 12 Nov 2026, citing other professional commitments. S. D. Mehta and Co. was appointed as replacement.
Tierra Agrotech Management Change
Tierra Agrotech appointed Sridevi Dasari as Executive Director for 60 months, effective 16 November 2026. She is Group Company Secretary and Legal Head of CCL Products (India).
- Execution
- 60 months
National Peroxide Management Change
National Peroxide Limited appointed Mr. Amit Shah as General Manager – Sales & Marketing, effective 11 November 2026, as a senior management personnel change. The appointment was approved at a board meeting held the same day.
Naperol Investments Management Change
Naperol Investments appointed Mr. Vinay Divakar Jayade as Non-Executive Non-Independent Director and Ms. Jinal Shah as Company Secretary, both effective 11 November 2026. Board-approved appointments with no financial value disclosed.
- Execution
- 3 months (Mr. Jayade's term of appointment)